Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 460

1.

A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants.

Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, Carlo WA, Ward RM, Shalwitz R, Baggs G, Seth A, Darko L.

Am J Perinatol. 2009 Mar;26(3):235-45. doi: 10.1055/s-0028-1103515. Epub 2008 Dec 9.

PMID:
19067286
[PubMed - indexed for MEDLINE]
2.

Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.

Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch M.

Pediatrics. 2003 Nov;112(5):e354.

PMID:
14595076
[PubMed - indexed for MEDLINE]
3.

Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants.

Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV.

JAMA. 1996 Feb 21;275(7):539-44.

PMID:
8606475
[PubMed - indexed for MEDLINE]
4.

Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants.

Sangtawesin C, Sangtawesin V, Lertsutthiwong W, Kanjanapattanakul W, Khorana M, Ayudhaya JK.

J Med Assoc Thai. 2008 Oct;91 Suppl 3:S28-34.

PMID:
19255990
[PubMed - indexed for MEDLINE]
5.

Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.

Cherif A, Jabnoun S, Khrouf N.

Am J Perinatol. 2007 Jun;24(6):339-45. Epub 2007 Jun 12.

PMID:
17564958
[PubMed - indexed for MEDLINE]
6.

Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.

Yang CZ, Lee J.

World J Pediatr. 2008 May;4(2):91-6. doi: 10.1007/s12519-008-0017-7.

PMID:
18661761
[PubMed - indexed for MEDLINE]
7.

Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.

Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L.

Ann Thorac Surg. 2006 Jan;81(1):231-4.

PMID:
16368371
[PubMed - indexed for MEDLINE]
8.

Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus.

Cherif A, Khrouf N, Jabnoun S, Mokrani C, Amara MB, Guellouze N, Kacem S.

Pediatrics. 2008 Dec;122(6):e1256-61. doi: 10.1542/peds.2008-1780.

PMID:
19047225
[PubMed - indexed for MEDLINE]
Free Article
9.

Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants.

Dani C, Bertini G, Reali MF, Murru P, Fabris C, Vangi V, Rubaltelli FF.

Acta Paediatr. 2000 Nov;89(11):1369-74.

PMID:
11106052
[PubMed - indexed for MEDLINE]
10.

An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.

Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S.

Br J Clin Pharmacol. 2008 May;65(5):629-36. doi: 10.1111/j.1365-2125.2008.03118.x. Epub 2008 Feb 27.

PMID:
18307541
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.

Supapannachart S, Limrungsikul A, Khowsathit P.

J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1252-8.

PMID:
12549803
[PubMed - indexed for MEDLINE]
12.

[Comparison of the efficacy of ibuprofen and indomethacin in the treatment of patent ductus arteriosus in prematurely born infants].

Adamska E, Helwich E, Rutkowska M, Zacharska E, Piotrowska A.

Med Wieku Rozwoj. 2005 Jul-Sep;9(3 Pt 1):335-54. Polish.

PMID:
16547381
[PubMed - indexed for MEDLINE]
13.

Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial.

Sosenko IR, Fajardo MF, Claure N, Bancalari E.

J Pediatr. 2012 Jun;160(6):929-35.e1. doi: 10.1016/j.jpeds.2011.12.031. Epub 2012 Jan 28.

PMID:
22284563
[PubMed - indexed for MEDLINE]
14.

Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants.

Erdeve O, Yurttutan S, Altug N, Ozdemir R, Gokmen T, Dilmen U, Oguz SS, Uras N.

Arch Dis Child Fetal Neonatal Ed. 2012 Jul;97(4):F279-83. doi: 10.1136/archdischild-2011-300532. Epub 2011 Dec 5.

PMID:
22147286
[PubMed - indexed for MEDLINE]
15.

Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial.

Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwé W, Jespers A, Weyler J, Harrewijn I, Langhendries JP.

Lancet. 2004 Nov 27-Dec 3;364(9449):1945-9.

PMID:
15567010
[PubMed - indexed for MEDLINE]
16.

Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.

Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, Hoekstra RE, Payne NR.

J Pediatr. 1996 May;128(5 Pt 1):631-7.

PMID:
8627434
[PubMed - indexed for MEDLINE]
17.

Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.

Su PH, Chen JY, Su CM, Huang TC, Lee HS.

Pediatr Int. 2003 Dec;45(6):665-70.

PMID:
14651538
[PubMed - indexed for MEDLINE]
18.

A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.

Chotigeat U, Jirapapa K, Layangkool T.

J Med Assoc Thai. 2003 Aug;86 Suppl 3:S563-9.

PMID:
14700149
[PubMed - indexed for MEDLINE]
19.

Therapeutic closure of the ductus arteriosus: benefits and limitations.

Mercanti I, Boubred F, Simeoni U.

J Matern Fetal Neonatal Med. 2009;22 Suppl 3:14-20. doi: 10.1080/14767050903198132. Review.

PMID:
19925358
[PubMed - indexed for MEDLINE]
20.

Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.

Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM.

J Clin Pharm Ther. 2005 Apr;30(2):121-32.

PMID:
15811164
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk